Treatment Options in Patients With Chronic GVHD

home / case-based-roundtable-series / treatment-options-in-patients-with-chronic-gvhd

This roundtable series examines systemic therapies and other options approvedin those with steroid-refractorychronic graft-vs-host disease, as discussed by key opinion leaders and participants at virtual live events.

Biology Informs Treatment Options for Steroid-Refractory Chronic GVHD

Biology Informs Treatment Options for Steroid-Refractory Chronic GVHD

Targeted Oncology Staff
February 22nd 2023

During a Targeted Oncology™ Case-Based Roundtable™ event, Noah M. Merin, MD, PhD, discussed biologic phases of chronic graft-vs-host disease and which therapies are available for patients who do not respond to steroids.

Using NCCN Guidelines for Chronic GVHD Therapy in Clinical Practice

Using NCCN Guidelines for Chronic GVHD Therapy in Clinical Practice

Targeted Oncology Staff
March 9th 2023

During a Targeted Oncology™ Case-Based Roundtable™ event, Noah M. Merin, MD, PhD, discussed 3 recommended agents for treatment of chronic graft-vs-host disease. This is the second of 2 articles based on this event.